MT Newswires5d agobullish
UBS Adjusts Price Target on Vertex Pharmaceuticals to $640 From $615, Maintains Buy RatingNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires5d agobullish
RBC Raises Price Target on Vertex Pharmaceuticals to $600 From $576, Keeps Outperform Rating